Oyster Point Pharma, Inc. Banner Image

Oyster Point Pharma, Inc.

  • Ticker OYST
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Oyster Point Pharma, Inc. Logo Image
  • 11-50 Employees
  • Based in Princeton, New Jersey
Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharma’s lead product candidate, OC-01 nasal spray, a highly selective cholinergic agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye diseaseMore. OC-01 nasal spray’s novel mechanism of action re-establishes tear film homeostasis by activating the trigeminal parasympathetic pathway to stimulate the glands and cells responsible for natural tear film production, known as the lacrimal functional unit (LFU).
4.8 / 5.0 (169)

Oyster Point Pharma, Inc. reports have an aggregate usefulness score of 4.8 based on 169 reviews.

Oyster Point Pharma, Inc.

Most Recent Annual Report

Oyster Point Pharma, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports

Oyster Point Pharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!